Do you have a dispute with a business?
Make it public
GREEN BIOLOGICS LIMITED
154AH BROOK DRIVE, MILTON PARK, ABINGDON, OXON, OX14 4SDPrevious name: BIOCLEAVE LIMITED (changed on 14-Aug-2023)
Previous name: GREEN BIOLOGICS LIMITED (changed on 25-Oct-2019)
Company Number: 04358718
Incorporation date: 23-Jan-2002
Status: Active
Entity type: Private Limited Company
SIC codes:
72110 Research and experimental development on biotechnology
74990 Non-trading company
SUMMARY
This company is 22.2 years old and is currently active. It is controlled by multiple entities. The company has positive equity (net assets) of USD 41.2 million which has increased from USD 12.9 million in the previous year. The latest reported revenue figure is USD 3.3 million which is up 70% on previous year's figure of USD 1.9 million. The company has 3 active officers (directors or partners) who are or were officers of 33 other companies, 12 (36.4%) of which have since been dissolved or are proposed for strike off. The company has no public disputes filed on the Business Disputes Register. There are no court cases involving the company that we are aware of.FINANCIALS (BETA)
Next accounts due: 31-Mar-2024Accounts Filed: TOTAL EXEMPTION FULL (30-Jun-2022)
P&L Financials:
Year end | Currency | Revenue | Operating profit | Interest Received | Interest Paid | Tax | Net Profit GBP |
---|---|---|---|---|---|---|---|
30-Jun-2019 | USD | 3,319,000 | -96,123,000 | 17,043,000 | 14,586,000 | -93,576,000 | |
31-Dec-2017 | USD | 1,922,000 | -22,430,000 | 7,735,000 | 8,059,000 | -22,615,000 | |
31-Dec-2016 | USD | 8,971,000 | -19,227,000 | 969,000 | 505,000 | -18,374,000 |
Balance Sheet Financials:
Year end | Currency | Cash | Current Assets | Current Liabilities | Debt | Share Capital | Premium Reserve | Retained Earnings | Net Assets |
---|---|---|---|---|---|---|---|---|---|
30-Jun-2019 | USD | 1,537,000 | 424,033,000 | 424,033,000 | 17,000 | 150,996,000 | 41,191,000 | ||
31-Dec-2017 | USD | 4,368,000 | 9,070,000 | 6,781,000 | 3,202,000 | 5,000 | 91,955,000 | -86,190,000 | 12,900,000 |
31-Dec-2016 | USD | 2,769,000 | 6,040,000 | 19,617,000 | 11,153,000 | 5,000 | 83,771,000 | -61,260,000 | 39,913,000 |
VALUATION EVENTS (BETA)
Year end | Currency | % Equity | Sum raised | Pre-Money Valuation* | Post-Money Valuation* | Enterprise Value** |
---|---|---|---|---|---|---|
30-Jun-2019 | USD | 70.59% | 59,053,000 | 24,605,417 | 83,658,417 | 264,796,917 |
** Estimated based on average Cash and Debt levels during period
DISPUTES
No disputes filed on www.disputesregister.orgCOMPANY SECRETARY
Status | Name | Appointed on | Resigned on | Occupation | Nationality | All apointments (active/resigned) |
---|---|---|---|---|---|---|
Resigned | Christina Margaret SWEENEY | 11 Sep 2008 | 30 Nov 2017 | British | 2 - 1 | |
Resigned | Judith Anne WESSELBAUM | 06 Dec 2005 | 11 Sep 2008 | Accountant | British | 1 - 4 |
Resigned | Karine Isabelle, Dr MAILLARD | 17 Jan 2005 | 06 Dec 2005 | 0 - 2 | ||
Resigned | ASHLEY SECRETARIES LIMITED | 23 Jan 2002 | 17 Jan 2005 | 0 - 78 |
DIRECTORS
Status | Name | Appointed on | Resigned on | Occupation | Nationality | All appointments (active/resigned) |
Dissolved companies (rate) |
---|---|---|---|---|---|---|---|
Resigned | Tamsin Denise CRANE | 26 Sep 2019 | 14 Dec 2020 | Solicitor | British | 0 - 1 | 0 (0.0%) |
Active | Karen Elizabeth STANLEY | 26 Sep 2019 | Financial Controller | British | 2 - 1 | 2 (66.7%) | |
Active | Elizabeth Rachael, Dr JENKINSON | 26 Sep 2019 | Scientist | British | 2 - 0 | 1 (50.0%) | |
Resigned | Paul Robert HENSON | 01 Jan 2019 | 26 Sep 2019 | Chartered Accountant | British | 1 - 8 | 2 (22.2%) |
Resigned | John Bruce RAE-SMITH | 01 Nov 2018 | 26 Sep 2019 | Company Director | British | 7 - 11 | 2 (11.1%) |
Resigned | Martin CUBBON | 01 Nov 2018 | 26 Sep 2019 | Director | British | 0 - 1 | 0 (0.0%) |
Resigned | Keon Alexander REED | 10 Oct 2018 | 26 Sep 2019 | Director | American | 0 - 1 | 0 (0.0%) |
Resigned | Brad PRITCHARD | 10 Oct 2018 | 26 Sep 2019 | Managing Director | American | 0 - 1 | 0 (0.0%) |
Resigned | Martin Incledon BLAIR | 01 Jan 2018 | 20 Jun 2019 | Director | British | 2 - 14 | 5 (31.3%) |
Resigned | Mark Noel WITT | 15 Jul 2015 | 14 Jul 2016 | Chief Financial Officer | American | 0 - 1 | 0 (0.0%) |
Resigned | Man Ching Maggie LEUNG | 15 Jul 2015 | 01 Jan 2019 | Management Executive | British | 0 - 1 | 0 (0.0%) |
Resigned | James Joseph HOHMAN | 01 Feb 2015 | 20 Jun 2019 | Retired Chemical Industry Executive | American | 0 - 1 | 0 (0.0%) |
Resigned | Philippe Paul LACAMP | 29 Nov 2013 | 15 Jul 2015 | General Management | British | 0 - 1 | 0 (0.0%) |
Resigned | Denis Jacques LUCQUIN | 29 Nov 2013 | 10 Oct 2018 | Managing Partner | French | 0 - 1 | 0 (0.0%) |
Resigned | Simon Iliff MANSFIELD | 20 Mar 2013 | 12 Jul 2017 | Private Investor | British | 0 - 1 | 0 (0.0%) |
Resigned | Joel Arthur STONE | 01 Jan 2012 | 29 Nov 2013 | Executive | Usa | 0 - 1 | 0 (0.0%) |
Resigned | Thomas James, Chief Financial Officer GROTE | 01 Jan 2012 | 15 Jul 2015 | Executive | Usa | 0 - 1 | 0 (0.0%) |
Resigned | Victor, Dr. CHRISTOU | 15 Dec 2010 | 19 Sep 2012 | Director | British | 0 - 9 | 5 (55.6%) |
Resigned | Reenie (Irene) MCCARTHY | 16 Jun 2010 | 29 Nov 2013 | Attorney | American | 0 - 2 | 0 (0.0%) |
Resigned | David John BRISTER | 01 Jun 2010 | 01 Nov 2018 | Director | British | 0 - 14 | 7 (50.0%) |
Resigned | Claude Jules Nestor STOUFS | 01 Jun 2010 | 10 Oct 2018 | Senior Investment Manager | Belgian | 0 - 1 | 0 (0.0%) |
Resigned | John Richard, Dr MARSH | 20 May 2009 | 18 Mar 2010 | Investment Manager | British | 0 - 3 | 2 (66.7%) |
Resigned | Simon Patrick David, Dr TURNER | 22 Apr 2009 | 15 Dec 2010 | Businessman | British | 4 - 6 | 2 (20.0%) |
Resigned | Gerald CHAN | 04 Feb 2009 | 16 Jun 2010 | Businessman | American | 0 - 6 | 1 (16.7%) |
Active | Sean George Cronin SUTCLIFFE | 29 Apr 2008 | Director | British | 7 - 30 | 12 (32.4%) | |
Resigned | Victor, Dr. CHRISTOU | 27 Sep 2007 | 11 May 2009 | Director | British | 0 - 9 | 5 (55.6%) |
Resigned | Andrew George, Dr RICKMAN | 30 Aug 2006 | 29 Nov 2013 | Engineer | British | 8 - 10 | 5 (27.8%) |
Resigned | Simon JONES | 01 May 2005 | 10 Apr 2006 | Company Director | British | 2 - 9 | 5 (45.5%) |
Resigned | Edward Timothy DAVIES | 11 Oct 2003 | 13 Dec 2010 | Research Scientist | British | 0 - 1 | 0 (0.0%) |
Resigned | Edward Mcconachie, Dr GREEN | 25 Jan 2003 | 29 Nov 2013 | Scientific Research | British | 1 - 2 | 0 (0.0%) |
Resigned | ASHLEY DIRECTORS LIMITED | 23 Jan 2002 | 25 Jan 2003 | 0 - 14 | 6 (42.9%) |
Average tenure of active directors: 8.3 years
Average tenure of resigned directors: 3.1 years
Average active director Dissolution Rate: 49.7%
DIRECTOR APPOINTMENTS IN OTHER COMPANIES
SHAREHOLDERS (BETA)
Shareholder name | Share class | Shares at confirmation date | ||||
---|---|---|---|---|---|---|
2020-01-23 | 2017-01-23 | 2016-01-23 | 2015-01-23 | 2014-01-23 | ||
ELIZABETH JENKINSON | ORDINARY | 52,016,484 37.5% | 0 0% | 0 0% | 0 0% | 0 0% |
TAMSIN CRANE | ORDINARY | 24,274,359 17.5% | 0 0% | 0 0% | 0 0% | 0 0% |
KAREN STANLEY | ORDINARY | 24,274,359 17.5% | 0 0% | 0 0% | 0 0% | 0 0% |
SEAN SUTCLIFFE | ORDINARY | 24,274,359 17.5% | 6,300 0.016% | 6,300 0.017% | 6,300 0.020% | 6,300 0.066% |
AMANDA HARDING | ORDINARY | 2,774,213 2.00% | 0 0% | 0 0% | 0 0% | 0 0% |
NATHAN FAIRHURST | ORDINARY | 2,774,213 2.00% | 0 0% | 0 0% | 0 0% | 0 0% |
CHRISTOPHER HILLS | ORDINARY | 2,080,659 1.50% | 0 0% | 0 0% | 0 0% | 0 0% |
ANNA BAKER | ORDINARY | 1,664,527 1.20% | 0 0% | 0 0% | 0 0% | 0 0% |
ARETHA ATMADJAJA | ORDINARY | 1,109,685 0.8% | 0 0% | 0 0% | 0 0% | 0 0% |
VERITY HOLBY | ORDINARY | 1,109,685 0.8% | 0 0% | 0 0% | 0 0% | 0 0% |
RACHEL HARPER | ORDINARY | 970,974 0.700% | 0 0% | 0 0% | 0 0% | 0 0% |
NICOLA WILLIAMS | ORDINARY | 554,843 0.400% | 0 0% | 0 0% | 0 0% | 0 0% |
BARBARA JONES | ORDINARY | 554,843 0.400% | 0 0% | 0 0% | 0 0% | 0 0% |
JAMES TYRRELL | ORDINARY | 138,711 0.100% | 0 0% | 0 0% | 0 0% | 0 0% |
TIMOTHY RAYMENT | ORDINARY | 138,711 0.100% | 0 0% | 0 0% | 0 0% | 0 0% |
CELL ENERGY LIMITED | B ORDINARY | 0 0% | 10,048,301 25.6% | 10,048,301 27.3% | 10,048,301 31.2% | 1,940,061 20.4% |
SOFINNOVA CAPITAL VII FCPR | B ORDINARY | 0 0% | 6,245,842 15.9% | 6,245,842 17.0% | 6,245,842 19.4% | 0 0% |
CELL ENERGY LIMITED | B1 ORDINARY | 0 0% | 2,762,166 7.04% | 1,675,049 4.56% | 0 0% | 0 0% |
CAPRICORN CLEANTECH FUND NV | B ORDINARY | 0 0% | 2,061,977 5.26% | 2,061,977 5.61% | 2,061,977 6.39% | 0 0% |
CONVERGINCE HOLDINGS, LLC | A ORDINARY | 0 0% | 2,004,586 5.11% | 2,004,586 5.45% | 2,004,586 6.21% | 0 0% |
CAPRICORN CLEANTECH FUND NV | A ORDINARY | 0 0% | 1,834,861 4.68% | 1,834,861 4.99% | 1,834,861 5.69% | 0 0% |
SOFINNOVA CAPITAL VII FCPR | B1 ORDINARY | 0 0% | 1,680,761 4.28% | 1,005,029 2.73% | 0 0% | 0 0% |
MORNINGSIDE VENTURE INVESTMENTS LIMITED | B ORDINARY | 0 0% | 1,380,997 3.52% | 1,380,997 3.76% | 1,380,997 4.28% | 408,009 4.29% |
SHARE NOMINEES LIMITED (HOLDING ON BEHALF OF THE OXFORD GATEWAY EIS PORTFOLIO) | B ORDINARY | 0 0% | 1,213,927 3.09% | 0 0% | 0 0% | 0 0% |
EDWARD GREEN | ORDINARY | 0 0% | 773,150 1.97% | 773,150 2.10% | 773,150 2.40% | 773,150 8.13% |
QUEST FOR GROWTH NV | B ORDINARY | 0 0% | 692,035 1.76% | 692,035 1.88% | 0 0% | 0 0% |
CONVERGINCE HOLDINGS, LLC | B ORDINARY | 0 0% | 671,293 1.71% | 671,293 1.83% | 671,293 2.08% | 0 0% |
SIMON MANSFIELD | B ORDINARY | 0 0% | 573,958 1.46% | 573,958 1.56% | 573,958 1.78% | 370,085 3.89% |
MORNINGSIDE VENTURE INVESTMENTS LTD | B1 ORDINARY | 0 0% | 535,938 1.37% | 335,009 0.911% | 0 0% | 0 0% |
CARBON TRUST INVESTMENT LIMITED | ORDINARY | 0 0% | 531,137 1.35% | 531,137 1.45% | 531,137 1.65% | 531,137 5.59% |
SHARE NOMINEES LIMITED | B ORDINARY | 0 0% | 418,484 1.07% | 418,484 1.14% | 418,484 1.30% | 15,291 0.161% |
ANDREW RICKMAN | ORDINARY | 0 0% | 417,824 1.07% | 417,824 1.14% | 417,824 1.30% | 417,824 4.40% |
MORNINGSIDE VENTURE INVESTMENTS LIMITED | A ORDINARY | 0 0% | 364,270 0.929% | 364,270 0.991% | 364,270 1.13% | 0 0% |
QUEST FOR GROWTH NV | B1 ORDINARY | 0 0% | 354,531 0.904% | 167,504 0.456% | 0 0% | 0 0% |
CARBON TRUST INVESTMENTS LIMITED | A ORDINARY | 0 0% | 344,332 0.878% | 344,332 0.937% | 344,332 1.07% | 0 0% |
FUND NO. 3 OXFORD GATEWAY | ORDINARY | 0 0% | 341,394 0.870% | 341,394 0.929% | 341,394 1.06% | 0 0% |
CAPRICORN CLEANTECH FUND NV | B1 ORDINARY | 0 0% | 335,009 0.854% | 335,009 0.911% | 0 0% | 0 0% |
MORNINGSIDE VENTURE INVESTMENTS LIMITED | ORDINARY | 0 0% | 314,985 0.803% | 314,985 0.857% | 314,985 0.977% | 314,985 3.31% |
SHARE NOMINEES LIMITED (HOLDING ON BEHALF OF THE OXFORD GATEWAY EIS PORTFOLIO) | A ORDINARY | 0 0% | 285,788 0.729% | 0 0% | 0 0% | 0 0% |
FUND NO 4 OXFORD GATEWAY | ORDINARY | 0 0% | 256,882 0.655% | 256,882 0.699% | 256,882 0.796% | 0 0% |
SHARE NOMINEES LIMITED | A ORDINARY | 0 0% | 238,532 0.608% | 238,532 0.649% | 238,532 0.740% | 238,532 2.51% |
JOEL STONE | ORDINARY | 0 0% | 194,358 0.495% | 0 0% | 0 0% | 0 0% |
MARTIN WOOD | ORDINARY | 0 0% | 190,083 0.485% | 190,083 0.517% | 190,083 0.589% | 0 0% |
AUDREY WOOD | ORDINARY | 0 0% | 190,083 0.485% | 190,083 0.517% | 190,083 0.589% | 190,083 2.00% |
CONVERGINCE HOLDINGS LLC | B1 ORDINARY | 0 0% | 130,509 0.333% | 83,752 0.228% | 0 0% | 0 0% |
ROBERT RICKMAN | ORDINARY | 0 0% | 128,764 0.328% | 100,000 0.272% | 100,000 0.310% | 100,000 1.05% |
AUDREY WOOD | A ORDINARY | 0 0% | 124,705 0.318% | 124,705 0.339% | 124,705 0.387% | 124,705 1.31% |
MARTIN WOOD | A ORDINARY | 0 0% | 124,705 0.318% | 124,705 0.339% | 124,705 0.387% | 124,705 1.31% |
ANDREW RICKMAN | A ORDINARY | 0 0% | 118,749 0.303% | 118,749 0.323% | 118,749 0.368% | 0 0% |
SIMON MANSFIELD | B1 ORDINARY | 0 0% | 107,887 0.275% | 67,001 0.182% | 0 0% | 0 0% |
GENBEST LIMITED | A ORDINARY | 0 0% | 100,917 0.257% | 100,917 0.275% | 100,917 0.313% | 0 0% |
SHARE NOMINEES LIMITED (HOLDING ON BEHALF OF THE OXFORD GATEWAY IHT PORTFOLIO) | B ORDINARY | 0 0% | 97,624 0.249% | 0 0% | 0 0% | 0 0% |
OXFORD GATEWAY FUND NO. 4 | A ORDINARY | 0 0% | 93,626 0.239% | 93,626 0.255% | 93,626 0.290% | 0 0% |
OXFORD GATEWAY FUND NO. 5 | A ORDINARY | 0 0% | 92,716 0.236% | 92,716 0.252% | 92,716 0.287% | 0 0% |
MARTIN WOOD | B ORDINARY | 0 0% | 78,787 0.201% | 78,787 0.214% | 78,787 0.244% | 0 0% |
AUDREY WOOD | B ORDINARY | 0 0% | 78,787 0.201% | 78,787 0.214% | 78,787 0.244% | 0 0% |
DBI PARTICIPATIONS BVBA | B ORDINARY | 0 0% | 69,203 0.176% | 69,203 0.188% | 0 0% | 0 0% |
OXFORD GATEWAY APPROVED EIS FUND NO. 5 09/10 | A ORDINARY | 0 0% | 56,880 0.145% | 56,880 0.155% | 56,880 0.176% | 0 0% |
EDWARD DAVIES | ORDINARY | 0 0% | 53,151 0.135% | 53,151 0.145% | 53,151 0.165% | 53,151 0.559% |
SEAN SUTCLIFFE | B ORDINARY | 0 0% | 51,901 0.132% | 51,901 0.141% | 51,901 0.161% | 0 0% |
ANDREW RICKMAN | B ORDINARY | 0 0% | 50,174 0.128% | 50,174 0.137% | 50,174 0.156% | 50,174 0.528% |
OXFORD GATEWAY IHT PORTFOLIO | A ORDINARY | 0 0% | 36,068 0.092% | 36,068 0.098% | 36,068 0.112% | 0 0% |
SHARE NOMINEES LTD. (HOLDING ON BEHALF OF THE OXFORD GATEWAY EIS PORTFOLIO (APPROVED) 2011 2012) | A ORDINARY | 0 0% | 35,532 0.091% | 0 0% | 0 0% | 0 0% |
SEAN SUTCLIFFE | A ORDINARY | 0 0% | 34,758 0.089% | 34,758 0.095% | 34,758 0.108% | 34,758 0.366% |
DBI PARTICIPATIONS BVBA | B1 ORDINARY | 0 0% | 33,500 0.085% | 33,500 0.091% | 0 0% | 0 0% |
JONATHAN GREEN | ORDINARY | 0 0% | 26,000 0.066% | 26,000 0.071% | 26,000 0.081% | 26,000 0.274% |
RENIA GEMMELL | ORDINARY | 0 0% | 20,000 0.051% | 20,000 0.054% | 20,000 0.062% | 0 0% |
ROBIN BUXTON | ORDINARY | 0 0% | 20,000 0.051% | 20,000 0.054% | 20,000 0.062% | 20,000 0.210% |
YUK SUNG | ORDINARY | 0 0% | 20,000 0.051% | 20,000 0.054% | 20,000 0.062% | 0 0% |
ROBERT RICKMAN | A ORDINARY | 0 0% | 19,301 0.049% | 19,301 0.053% | 19,301 0.060% | 19,301 0.203% |
SEAN SUTCLIFFE | B1 ORDINARY | 0 0% | 19,142 0.049% | 10,050 0.027% | 0 0% | 0 0% |
ANDREW DOBLE | A ORDINARY | 0 0% | 15,291 0.039% | 15,291 0.042% | 15,291 0.047% | 0 0% |
ANDREW DOBLE | B ORDINARY | 0 0% | 11,992 0.031% | 11,992 0.033% | 11,992 0.037% | 11,992 0.126% |
ALAN MOORHOUSE | ORDINARY | 0 0% | 10,515 0.027% | 10,515 0.029% | 10,515 0.033% | 10,515 0.111% |
ANDREW DOBLE | B1 ORDINARY | 0 0% | 10,193 0.026% | 10,193 0.028% | 0 0% | 0 0% |
MARY MOORHOUSE | ORDINARY | 0 0% | 10,000 0.025% | 10,000 0.027% | 10,000 0.031% | 10,000 0.105% |
KATHLYN MOORHOUSE | ORDINARY | 0 0% | 10,000 0.025% | 10,000 0.027% | 10,000 0.031% | 0 0% |
TERRY BICKENSON | ORDINARY | 0 0% | 7,340 0.019% | 7,340 0.020% | 7,340 0.023% | 7,340 0.077% |
JOHN WARREN | ORDINARY | 0 0% | 7,083 0.018% | 7,083 0.019% | 0 0% | 0 0% |
TIMOTHY HARRIS | ORDINARY | 0 0% | 6,168 0.016% | 6,168 0.017% | 6,168 0.019% | 6,168 0.065% |
MICHAEL WRIGHT | ORDINARY | 0 0% | 6,000 0.015% | 6,000 0.016% | 6,000 0.019% | 0 0% |
EDWARD GREEN | A ORDINARY | 0 0% | 5,760 0.015% | 5,760 0.016% | 5,760 0.018% | 0 0% |
SIMON JONES | ORDINARY | 0 0% | 5,250 0.013% | 5,250 0.014% | 5,250 0.016% | 5,250 0.055% |
EDWARD GREEN | B ORDINARY | 0 0% | 4,499 0.011% | 4,499 0.012% | 4,499 0.014% | 4,499 0.047% |
SCOTT WARFIELD | ORDINARY | 0 0% | 4,000 0.010% | 0 0% | 0 0% | 0 0% |
THOMAS GROTE | B1 ORDINARY | 0 0% | 3,480 0.009% | 0 0% | 0 0% | 0 0% |
KRIS WADROP | A ORDINARY | 0 0% | 2,895 0.007% | 2,895 0.008% | 2,895 0.009% | 2,895 0.030% |
EDWARD TIM DAVIES | A ORDINARY | 0 0% | 2,573 0.007% | 2,573 0.007% | 2,573 0.008% | 0 0% |
SHARE NOMINEES LIMITED | B1 ORDINARY | 0 0% | 2,548 0.006% | 2,548 0.007% | 0 0% | 0 0% |
EGLE THOMAS | ORDINARY | 0 0% | 2,500 0.006% | 2,500 0.007% | 2,500 0.008% | 0 0% |
SOPHIE CALLAGHAN | ORDINARY | 0 0% | 2,000 0.005% | 2,000 0.005% | 2,000 0.006% | 2,000 0.021% |
DIANE SIMMONS | ORDINARY | 0 0% | 2,000 0.005% | 2,000 0.005% | 2,000 0.006% | 2,000 0.021% |
FERGAL O'BRIEN | A ORDINARY | 0 0% | 1,994 0.005% | 1,994 0.005% | 1,994 0.006% | 0 0% |
KRIS WADROP | ORDINARY | 0 0% | 1,890 0.005% | 1,890 0.005% | 1,890 0.006% | 1,890 0.020% |
CHRISTINA SWEENEY | A ORDINARY | 0 0% | 1,286 0.003% | 1,286 0.003% | 1,286 0.004% | 1,286 0.014% |
HAIRONG CAI | ORDINARY | 0 0% | 1,000 0.003% | 0 0% | 1,000 0.003% | 0 0% |
ROSA DOMINGUEZ | ORDINARY | 0 0% | 600 0.002% | 600 0.002% | 600 0.002% | 600 0.006% |
SHARE NOMINEES LIMITED (HOLDING ON BEHALF OF THE OXFORD GATEWAY EIS | B ORDINARY | 0 0% | 0 0% | 1,213,927 3.30% | 1,213,927 3.76% | 0 0% |
SHARE NOMINEES LIMITED (HOLDING ON BEHALF OF THE OXFORD GATEWAY EIS | A ORDINARY | 0 0% | 0 0% | 285,788 0.778% | 285,788 0.886% | 0 0% |
SHARE NOMINEES LIMITED (HOLDING ON BEHALF OF THE OXFORD GATEWAY IHT | B ORDINARY | 0 0% | 0 0% | 97,624 0.266% | 97,624 0.303% | 0 0% |
SHARE NOMINEES LTD. (HOLDING ON BEHALF OF THE OXFORD GATEWAY EIS | A ORDINARY | 0 0% | 0 0% | 35,532 0.097% | 35,532 0.110% | 0 0% |
MARK WITT | B1 ORDINARY | 0 0% | 0 0% | 6,700 0.018% | 0 0% | 0 0% |
HAIRONG CAT | ORDINARY | 0 0% | 0 0% | 1,000 0.003% | 0 0% | 0 0% |
CAPRICOM CLEANTECH FUND NV | B ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 1,088,989 11.5% |
SHARE NOMINEES LTD (HIDG OBO THE OXFORD GATEWAY EIS PORTFOLIO) | B ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 727,681 7.65% |
CONVERGINCE HOLDINGS LLC | B ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 541,562 5.70% |
SHARE NOMINEES LTD (HOLDING ON BEHALF OF OXFORD GATEWAY FUND 3) | ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 341,394 3.59% |
SHARE NOMINEES (HOLDING OBO OXFORD GATEWAY EIS PORTFOLIO) | A ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 285,788 3.01% |
SHARE NOMINEES LTD (HOLDING ON BEHALF OF OXFORD GATEWAY FUND 4) | ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 256,882 2.70% |
SHARE NOMINEES (HOLDING ON BEHALF OF OXFORD GATEWAY FUND 4) | A ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 93,626 0.985% |
SHARE NOMINEES (HOLDING ON BEHALF OF OXFORD GATEWAY FUND 5) | A ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 92,716 0.975% |
SHARE NOMINEES LTD (HIDG OBO THE OXFORD GATEWAY IHT PORTFOLIO) | B ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 74,186 0.780% |
SHARE NOMINEES(HIDG OBO OXFORD GATEWAY APPR'D EIS FUND 5 0910) | A ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 56,880 0.598% |
SHARE NOMINEES(HOLDING ON BEHALF OF OXFORD GATEWAY IHT PORTFOLIO) | A ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 36,068 0.379% |
SHARE NOMINEES(HIDG OBO OXFORD GATEWAY EIS PORTFOLIO APPRD 11-12 | A ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 35,532 0.374% |
YUK LING SUNG | ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 20,000 0.210% |
RENA GEMMELL | ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 20,000 0.210% |
KATHRYN MOORHOUSE | ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 10,000 0.105% |
SHAREHOLDINGS (BETA)
no shareholding data
CONTROLLED COMPANIES / CONTROLLING ENTITIES
Controlling entities above
GREEN BIOLOGICS LIMITED
no controlled companies
LATE PAYMENTS REPORT
This company has not filed any late payment reports possibly because it is not considered \'Large\'.
COURT CASES
No Court Cases found
PATENTS
Title | Date filed | Status | Publication number |
---|---|---|---|
Targeted mutations | 2015-04-16 | Granted | GB2530831 |
Deletion mutations | 2015-04-16 | Granted | GB2530832 |
Solvent production using monophasic clostridia | 2014-06-27 | Granted | GB2520101 |
Production of butanol | 2014-02-05 | Terminated | GB2515366 |
Cyclodextrin glucanotransferase from Clostridium saccharoperbutylacetonicum strains | 2014-02-05 | Granted | GB2515367 |
Solvent production by continuous microbiological culture | 2012-07-23 | Granted | GB2505638 |
Production of butanol using thermophilic Bacillaceae | 2009-04-03 | Granted | GB2458818 |
Butanol and Other Alcohol Production Process | 2009-02-27 | Granted | GB2457820 |
Process for producing butyric acid and other acids using electrochemical reactor | 2009-02-27 | Terminated | GB2469758 |
COMPETITORS
(Based on Sic code:
72110 Research and experimental development on biotechnology)
Company | Registered Address | Company Number | YE Date | Revenue GBP | Net Profit GBP | Other SIC codes |
---|---|---|---|---|---|---|
ILLUMINA CAMBRIDGE LIMITED | 19 GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, CAMBRIDGESHIRE, ENGLAND, CB21 6DF | 03625145 | 2017-12-31 | 2,114,848,000 | 422,140,000 | |
IQVIA LTD. | 3 FORBURY PLACE, 23 FORBURY ROAD, READING, UNITED KINGDOM, RG1 3JH | 03022416 | 2017-12-31 | 1,123,545,000 | 198,818,000 | |
AMGEN LIMITED | 216 CAMBRIDGE SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CAMBRIDGESHIRE, ENGLAND, CB4 0WA | 02354269 | 2017-12-31 | 238,931,000 | 9,488,000 | |
GENOME RESEARCH LIMITED | WELLCOME SANGER INSTITUTE WELLCOME GENOME CAMPUS, HINXTON, SAFFRON WALDEN, ENGLAND, CB10 1SA | 02742969 | 2018-09-30 | 144,812,000 | 55,555,000 | |
COVANCE LABORATORIES LIMITED | OTLEY RD, HARROGATE, HG3 1PY | 01171833 | 2017-12-31 | 111,519,000 | 16,839,000 | |
ASTEX THERAPEUTICS LIMITED | 436 CAMBRIDGE SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CB4 0QA | 03751674 | 2018-12-31 | 72,199,766 | 28,006,138 | |
CELLTECH R&D LIMITED | 208 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3WE | 01472269 | 2017-12-31 | 55,407,000 | -5,338,000 | |
QUOTIENT SCIENCES LIMITED | TRENT HOUSE MERE WAY, RUDDINGTON FIELDS BUSINESS PARK, RUDDINGTON, NOTTINGHAM, NG11 6JS | 05221615 | 2018-03-31 | 43,379,000 | 7,170,000 | |
CENTRE FOR PROCESS INNOVATION LIMITED | WILTON CENTRE, WILTON, REDCAR, CLEVELAND, TS10 4RF | 05002194 | 2018-03-31 | 33,187,000 | 7,344,000 |
72190-Other research and experimental development on natural sciences and engineering 82990-Other business support service activities not elsewhere classified 85320-Technical and vocational secondary education |
EVOTEC (UK) LIMITED | 114 INNOVATION DRIVE, MILTON PARK, MILTON, ABINGDON, OXFORDSHIRE, OX14 4RZ | 02674265 | 2017-12-31 | 31,859,000 | 1,599,000 | |
ARC TRINOVA LIMITED | C/O QUOTIENT SCIENCES LIMITED TRENT HOUSE MERE WAY, RUDDINGTON FIELDS BUSINESS PARK, RUDDINGTON, NOTTINGHAM, ENGLAND, NG11 6JS | 09767194 | 2017-12-31 | 8,422,519 | 0 | |
CROWN BIOSCIENCE UK LIMITED | BUILDING 14 DODGEFORD LANE, OSGATHORPE, LOUGHBOROUGH, LEICESTERSHIRE, LE12 9TE | 07109059 | 2017-12-31 | 2,819,775 | 0 | |
INDUSTRIAL MICROBIOLOGICAL SERVICES LIMITED | ODD FELLOWS HALL, 118B OXFORD ROAD, READING, RG1 7NG | 03264423 | 2018-01-31 | 1,005,784 | 0 | |
THE BIO NANO CENTRE UNLIMITED | 69 ONSLOW ROAD, ONSLOW ROAD, RICHMOND, ENGLAND, TW10 6QA | 06389520 | 2018-02-28 | 974,607 | 0 | |
TAILORED CLINICAL RESEARCH SOLUTIONS LIMITED | 2 HINKSEY COURT, CHURCH WAY, OXFORD, ENGLAND, OX2 9SX | 09930195 | 2017-12-31 | 334,157 | 0 |
86900-Other human health activities |
NEXT CLINICAL RESEARCH ORGANISATION LIMITED | 47 THE RIDGEWAY, FRIERN BARNET, LONDON, ENGLAND, N11 3LG | 09418105 | 2018-12-31 | 282,733 | 0 | |
MEDEZRIN LTD. | 71-75 SHELTON STREET, COVENT GARDEN, LONDON, UNITED KINGDOM, WC2H 9JQ | 03340737 | 2018-03-31 | 170,000 | 0 | |
NEW DIAGNOSTICS LIMITED | KNOLE VIEW, SOUTH HILL, SOMERTON, SOMERSET, TA11 7JQ | 08672341 | 2019-03-31 | 104,307 | 0 |
74909-Other professional, scientific and technical activities not elsewhere classified |
CLINICAL PHASE DEVELOPMENT LTD | 38 CABERFEIGH CLOSE, REDHILL, ENGLAND, RH1 6BF | 07715640 | 2018-07-31 | 94,690 | 0 | |
SEE-THROUGH SCIENTIFIC LIMITED | HARWOOD HOUSE, 43 HARWOOD ROAD, LONDON, ENGLAND, SW6 4QP | 09410281 | 2017-12-31 | 76,514 | 0 | |
DIAGNODUS LTD | ST JOHN'S INNOVATION CENTRE, COWLEY ROAD, CAMBRIDGE, ENGLAND, CB4 0WS | 07600875 | 2019-04-30 | 63,322 | 0 | |
FISHER STATISTICS CONSULTANCY LIMITED | 10 10 HEDGHOG CRESCENT, EDINBURGH, EH17 8XP, UNITED KINGDOM, EH17 8XP | SC385170 | 2018-09-30 | 54,959 | 0 |
72200-Research and experimental development on social sciences and humanities 85600-Educational support services |
SERNAT LIMITED | 173 BROADWAY, DIDCOT, ENGLAND, OX11 8RZ | 10372226 | 2017-09-30 | 51,815 | 0 |
72200-Research and experimental development on social sciences and humanities 86210-General medical practice activities |
COULSON BIOINFORMATICS LTD | EXCHANGE BUILDING, 66 CHURCH STREET, HARTLEPOOL, UNITED KINGDOM, TS24 7DN | 10904839 | 2018-08-31 | 48,628 | 0 | |
IHG PHARMACO LIMITED | 20-22 WENLOCK ROAD, LONDON, N1 7GU | 05606880 | 2018-03-31 | 43,960 | 0 | |
CALA PHARMA LIMITED | 5 FARRIERS WAY, WINSFORD, ENGLAND, CW7 2TS | 09883439 | 2017-11-30 | 35,084 | 0 | |
GOLGENE TECHNOLOGIES LIMITED | 24 CHELWOOD AVENUE, LEEDS, ENGLAND, LS8 2AZ | 06069931 | 2019-01-31 | 35,041 | 0 | |
GREENSTONE BIOLABS LTD | 024, WESTBOURNE STUDIOS, ACKLAM ROAD, LONDON, ENGLAND, W10 5JJ | 09874376 | 2017-11-30 | 33,043 | 0 |
72190-Other research and experimental development on natural sciences and engineering |
APPLIED EXOMICS LTD | LEE LARCOMBE, 39 HOGSDEN LEYS, ST. NEOTS, CAMBRIDGESHIRE, PE19 6AD | 08251827 | 2018-10-14 | 15,705 | 0 | |
SP SCIENTIFIC SERVICES LTD | 52 ANGEL HILL, SUTTON, UNITED KINGDOM, SM1 3EW | 10312528 | 2018-08-31 | 15,229 | 0 |
72190-Other research and experimental development on natural sciences and engineering |
CHEMOVATION LIMITED | WA10 1GH, 49 ARRIVATO PLAZA, HALL STREET, ST HELENS, UNITED KINGDOM, WA10 1GH | 05316858 | 2018-12-31 | 12,182 | 0 |
74909-Other professional, scientific and technical activities not elsewhere classified |
AXONICS MODULATION TECHNOLOGIES, U.K. LIMITED | 5TH FLOOR, ONE NEW CHANGE, LONDON, UNITED KINGDOM, EC4M 9AF | 09622653 | 2019-06-30 | 8,610 | 0 | |
RIOTECH PHARMACEUTICALS LIMITED | 49 ARRIVATO PLAZA,, HALL STREET, ST HELENS, UNITED KINGDOM, WA10 1GH | 04316377 | 2018-11-30 | 8,428 | 0 | |
GENOMEX LTD | BEECHCROFT DIKELANDS LANE, UPPER POPPLETON, YORK, UNITED KINGDOM, YO26 6JA | 10356872 | 2018-09-30 | 7,923 | 0 |
72190-Other research and experimental development on natural sciences and engineering |
ALLERAYDE SAB LIMITED | 1 MEADOW ROAD, NEWARK, NG24 3BP | 07909304 | 2019-01-31 | 4,348 | 0 | |
BIOMEMS TECHNOLOGIES LIMITED | 272 THE HAWTHORNS, CARDIFF, WALES, CF23 7AN | 09360659 | 2018-12-31 | 3,000 | 0 | |
OXFORD MEDISTRESS LTD | FLAT 1, 69, ONSLOW ROAD, RICHMOND, SURREY, ENGLAND, TW10 6QA | 05470178 | 2017-06-30 | 2,589 | 0 |
86900-Other human health activities |
ALCHEMY PHARMATECH LIMITED | KIRKSTONE GRINDLETON ROAD, WEST BRADFORD, CLITHEROE, LANCASHIRE, BB7 4TB | 07912825 | 2017-03-31 | 1,981 | 0 | |
PHYTOFUTURES LTD | 54 DAWLISH ROAD, LONDON, ENGLAND, E10 6QD | 09412092 | 2019-01-31 | 637 | 0 |
74909-Other professional, scientific and technical activities not elsewhere classified |
ALBANY CLINICAL CONSULTING LIMITED | 7 NEW BROUGHTON, EDINBURGH, MIDLOTHIAN, UNITED KINGDOM, EH3 6PA | SC532187 | 2018-04-30 | 295 | 0 | |
DYAX LTD | 1 KINGDOM STREET, LONDON, ENGLAND, W2 6BD | 08965623 | 2017-12-31 | 0 | 0 |
99999-Dormant Company |
ACUBLATE LIMITED | ANGEL BUILDING, 407 ST. JOHN STREET, LONDON, EC1V 4AD | 07209117 | 2018-03-31 | 0 | 0 | |
ARWAIN YMLAEN LIMITED | 32 CEDAR AVENUE, HAZLEMERE, HIGH WYCOMBE, HP15 7DW | 06062248 | 2019-03-31 | 0 | 0 | |
CELL RESEARCH TECHNOLOGY LTD | 32 FRIENDSHIP ROAD, BRISTOL, BS4 2RN | 08192207 | 2018-08-31 | 0 | 0 | |
DE NOVO PHARMACEUTICALS LIMITED | MAYPOLE COTTAGE LOWER GREEN, WIMBISH, SAFFRON WALDEN, ENGLAND, CB10 2XH | 03761178 | 2018-09-30 | 0 | 0 | |
FERTILITY INNOVATIONS LIMITED | COOMBE HOUSE, BRADFORD PEVERELL, DORCHESTER, DORSET, DT2 9SE | 07416896 | 2018-12-31 | 0 | 0 | |
GARSINGTON TECHNOLOGIES LIMITED | 4, THE GABLES, VALE OF HEALTH, HAMPSTEAD, LONDON, ENGLAND, NW3 1AY | 08782927 | 2018-11-30 | 0 | 0 | |
IOTA PHARMACEUTICALS LIMITED | ST JOHNS INNOVATION CENTRE, COWLEY ROAD, CAMBRIDGE, CAMBRIDGESHIRE, CB4 0WS | 06279987 | 2018-06-30 | 0 | 0 | |
LIF NANO RX LTD | APARTMENT 16 SPRINGS COURT, FIELD CLOSE, COTTINGHAM, ENGLAND, HU16 5GX | 08551193 | 2018-05-31 | 0 | 0 | |
MARBLEAMBER LIMITED | 29 GLADSTONE STREET, HATHERN, LOUGHBOROUGH, LEICESTERSHIRE, LE12 5LE | 07121238 | 2019-03-31 | 0 | 0 | |
NANO-NOSE LIMITED | 41 OAKWOOD PARK ROAD, LONDON, ENGLAND, N14 6QD | 11014188 | 2018-07-31 | 0 | 0 | |
PT VENTURES LIMITED | 1A TOWER ROAD, DARTFORD, ENGLAND, DA1 2HE | 09821026 | 2018-10-31 | 0 | 0 | |
W C LEE LIMITED | 94 HOWARD AVENUE, SLOUGH, BERKSHIRE, ENGLAND, SL2 1LA | 09508311 | 2018-03-31 | 0 | 0 | |
WALTERSTEAD LIMITED | ACADEMY HOUSE, SHEDDEN PARK ROAD, KELSO, ROXBURGHSHIRE, TD5 7AL | SC368318 | 2018-03-31 | 0 | 0 |
75000-Veterinary activities 82990-Other business support service activities not elsewhere classified |
RESPIRATORY CLINICAL TRIALS LIMITED | 1 TOWER HOUSE, TOWER CENTRE, HODDESDON, HERTFORDSHIRE, ENGLAND, EN11 8UR | 04063160 | 0000-00-00 | 0 | 0 |
LIQUIDATION RISK (BETA)
This company is Active. Statistically, Active companies have a low probability of being liquidated within a year.
Here are our probability predictions:
Basis | Liquidation within 3 months | Liquidation within 6 months | Liquidation within 12 months | Prediction confidence |
---|---|---|---|---|
GREEN BIOLOGICS LIMITED | 0.8% | 2.7% | 4.9% | Medium |
Other companies Active in the same sector | 1.2% | 3.5% | 7.4% | Medium |
Age | 0.3% | 1.3% | 2.4% | Medium |
Company Type | 0.7% | 3.7% | 7.4% | Medium |
Accounts category | 0.5% | 2.1% | 4.2% | Medium |
Accounting Month | 0.7% | 5.7% | 7.5% | Medium |
Sic code count | 0.8% | 3.8% | 7.5% | Medium |